Statement by the Sabin Vaccine Institute on Dr. Ciro de Quadros’ PAHO Public Health Hero of the Americas Award

Dr. Ciro de Quadros, Sabin Vaccine Institute’s Executive Vice President and Director of Vaccine Advocacy and Education, received the Public Health Hero of the Americas Award on April 25, 2014. The award is the highest honor bestowed by the Pan American Health Organization (PAHO). It was announced during Sabin’s 20th Anniversary Scientific Symposium, which was held at PAHO headquarters in Washington, DC.

Dr. Mathuram Santosham Receives 2014 Albert B. Sabin Gold Medal Award

WASHINGTON, D.C. – April 29, 2014 – The Sabin Vaccine Institute today will present its annual Albert B. Sabin Gold Medal Award to Dr. Mathuram Santosham for his pioneering role in the prevention of deadly H. influenzae type b (Hib) diseases, including pediatric bacterial meningitis and pneumonia. Dr. Santosham’s leadership in conducting groundbreaking research, vaccine efficacy trials and advocacy to prioritize Hib vaccines spans more than 40 years and has saved millions of children’s lives worldwide.

Sabin Vaccine Institute Hosts 20th Anniversary Scientific Symposium

WASHINGTON, D.C. – April 25, 2014 – Twenty years ago, the immunization landscape was starkly different from what it is now. More than 100,000 cases of poliomyelitis and 1.2 million cases of measles occurred each year, and few low-income countries outside of the Americas had immunization plans. Neglected tropical diseases (NTDs), which have existed since biblical times, wreaked havoc without recognition due to an absence of coordinated advocacy and government funding.

Dengue Vaccine Initiative awarded grant from Germany for development of new dengue vaccines in Brazil and Vietnam

SEOUL, SOUTH KOREA - The Dengue Vaccine Initiative (DVI) announced today that it has received a 1 million Euro award from the German Federal Ministry of Education and Research (BMBF), the first time it has received such a grant from Germany. The funds will be used to support the development of new dengue vaccines in collaboration with the Instituto Butantan, a biomedical research center in São Paulo, Brazil, and Vabiotech, a vaccine manufacturer in Hanoi, Vietnam.